510(k) K032796

IBL C3D-CIC EIA TEST by Ibl GmbH — Product Code CZW

K032796 is an FDA 510(k) premarket notification submitted by Ibl GmbH for the device "IBL C3D-CIC EIA TEST". The FDA issued a decision of Substantially Equivalent on January 13, 2004. The device falls under product code CZW (Complement C3, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5240. Ibl GmbH has at least 5 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
January 13, 2004
Date Received
September 8, 2003
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Complement C3, Antigen, Antiserum, Control
Device Class
Class II
Regulation Number
866.5240
Review Panel
IM
Submission Type